Side-by-side comparison
Edwards Lifesciences vs Medtronic
As of Nov 11, 2026, P/E is 59.3x for Edwards Lifesciences vs 24.9x for Medtronic; P/S is 9.0x for Edwards Lifesciences vs 3.4x for Medtronic; revenue growth is 13.4% for Edwards Lifesciences vs 9.8% for Medtronic; operating margin is 21.6% for Edwards Lifesciences vs 18.1% for Medtronic.
What stands out
- Medtronic is cheaper on earnings: 24.9x P/E vs 59.3x for Edwards Lifesciences.
- Edwards Lifesciences carries less debt relative to equity: 0.06 vs 0.51 for Medtronic.
- Edwards Lifesciences's shares did better over the past year: +22.7% vs +5.5% for Medtronic.
Key metrics
| Metric | EW | MDT |
|---|---|---|
| Price | $104.98 | $101.12 |
| Market cap | $60.36B | $129.34B |
| P/E | 59.3x (#2) | 24.9x (#1) |
| P/S | 9.0x (#2) | 3.4x (#1) |
| Revenue growth | 13.4% (#1) | 9.8% (#2) |
| Operating margin | 21.6% (#1) | 18.1% (#2) |
| Net margin | 15.3% (#1) | 13.9% (#2) |
| Debt / equity | 0.06 (#1) | 0.51 (#2) |
| 1-year return | +22.7% (#1) | +5.5% (#2) |
| Research score | 66/100 (#1) | 63/100 (#2) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Edwards Lifesciences Corporation (EW) — Medical Devices
- Medtronic plc (MDT) — Medical Devices